MSK is committed to the discovery and development of new tools and therapeutic agents for cancer detection, prevention, and treatment. The mission of the Organic Synthesis Core is to provide chemical synthesis services to Center members through a state-of-the art facility staffed by expert professional personnel in chemical synthesis. The Core operates at the interface of chemistry, biology, and medicine, and has the capability of supporting medicinal chemistry efforts to produce and evolve lead candidates and tool compounds in support of Center investigators. The work of the Core has greatly facilitated preclinical studies at the Center. The Core synthesizes novel molecules that are not readily available, by either following described procedures, or by developing new and more suitable methods of synthesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-53
Application #
9631236
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
53
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Owen, Dwight; Chaft, Jamie E (2018) Immunotherapy in surgically resectable non-small cell lung cancer. J Thorac Dis 10:S404-S411
Gill, Samuel C; Lim, Nathan M; Grinaway, Patrick B et al. (2018) Binding Modes of Ligands Using Enhanced Sampling (BLUES): Rapid Decorrelation of Ligand Binding Modes via Nonequilibrium Candidate Monte Carlo. J Phys Chem B 122:5579-5598
Vorkas, Charles Kyriakos; Wipperman, Matthew F; Li, Kelin et al. (2018) Mucosal-associated invariant and ?? T cell subsets respond to initial Mycobacterium tuberculosis infection. JCI Insight 3:
Li, Xiang; Li, Tianfang; Yorke, Ellen et al. (2018) Effects of irregular respiratory motion on the positioning accuracy of moving target with free breathing cone-beam computerized tomography. Int J Med Phys Clin Eng Radiat Oncol 7:173-183
Jain, Devanshi; Puno, M Rhyan; Meydan, Cem et al. (2018) ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2. Elife 7:
Laird, James; Lok, Benjamin; Siu, Chun et al. (2018) Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy. Ann Surg Oncol 25:154-163
Leeman, Jonathan E; McBride, Sean M; Spielsinger, Daniel et al. (2018) Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks. Int J Cancer 142:2485-2490
Reiner, Anne S; Sisti, Julia; John, Esther M et al. (2018) Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 36:1513-1520
Bhatia, Ankush; Ulaner, Gary; Rampal, Raajit et al. (2018) Single-agent dabrafenib for BRAFV600E-mutated histiocytosis. Haematologica 103:e177-e180
Khalil, Danny N; O'Reilly, Eileen M (2018) Classification of Pancreatic Cancer: Ready for Practical Application? Clin Cancer Res 24:4355-4356

Showing the most recent 10 out of 8799 publications